These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2973587)

  • 1. [Pharmacokinetics of ceftazidime in cystic fibrosis].
    Saint Raymond A; Genillier P; Lenoir G
    Presse Med; 1988 Oct; 17(37):1925-7. PubMed ID: 2973587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.
    Hedman A; Adan-Abdi Y; Alvan G; Strandvik B; Arvidsson A
    Clin Pharmacokinet; 1988 Jul; 15(1):57-65. PubMed ID: 3042246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceftazidime absorption into bronchial secretions in mucoviscidosis patients].
    Berthelot G; Lenoir G; Grenier B; Tournier G; Sardet A; Steru D; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):430-4. PubMed ID: 3897974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients.
    Byl B; Baran D; Jacobs F; Herschuelz A; Thys JP
    J Antimicrob Chemother; 2001 Aug; 48(2):325-7. PubMed ID: 11481316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Age-related characteristics of ceftazidime pharmacokinetics in children].
    Prokhorenko PI; Strachunskiĭ LS; Andreenkova EG; Portnoĭ IuA; Firsov AA
    Antibiot Khimioter; 1992 Jun; 37(6):29-31. PubMed ID: 1417341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit.
    Mouton JW; Punt N; Vinks AA
    Clin Ther; 2005 Jun; 27(6):762-72. PubMed ID: 16117983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ceftazidime after intravenous, intramuscular and subcutaneous administration to dogs.
    Monfrinotti A; Ambros L; Prados AP; Kreil V; Rebuelto M
    J Vet Pharmacol Ther; 2010 Apr; 33(2):204-7. PubMed ID: 20444047
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.
    Vinks AA; Touw DJ; Heijerman HG; Danhof M; de Leede GP; Bakker W
    Ther Drug Monit; 1994 Aug; 16(4):341-8. PubMed ID: 7974622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections.
    Stamper MA; Papich MG; Lewbart GA; May SB; Plummer DD; Stoskopf MK
    J Zoo Wildl Med; 1999 Mar; 30(1):32-5. PubMed ID: 10367641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of ceftazidime into bronchial secretions in critically ill patients.
    Langer M; Cantoni P; Bellosta C; Boccazzi A
    J Antimicrob Chemother; 1991 Dec; 28(6):925-32. PubMed ID: 1816189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.
    Jonsson M; Walder M
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):15-21. PubMed ID: 1563378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime pharmacokinetics in preterm newborns on the first day of life.
    Padovani EM; Fanos V; Dal Moro A; Chiaffoni GP; Fostini R; Girelli M; Boner A
    Biol Res Pregnancy Perinatol; 1986; 7(2):71-3. PubMed ID: 3524697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of ceftazidime in healthy and renal failure subjects].
    Leroy A; Fillastre JP; Humbert G; Borsa F; Leguy F; Spencer GR
    Presse Med; 1988 Oct; 17(37):1917-20. PubMed ID: 2973585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy.
    Vinks AA; Mouton JW; Touw DJ; Heijerman HG; Danhof M; Bakker W
    Antimicrob Agents Chemother; 1996 May; 40(5):1091-7. PubMed ID: 8723446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ceftazidime given alone and combination with probenecid to unweaned calves.
    Soback S; Ziv G
    Am J Vet Res; 1989 Sep; 50(9):1566-9. PubMed ID: 2679252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.